qRT-PCR (quantitative reverse transcription polymerase chain reaction) is a lab technique that measures how much of a specific RNA molecule is present in a sample. It works in two stages: first converting RNA into DNA, then amplifying that DNA while tracking the amount produced in real time. This makes it one of the most sensitive methods available for detecting gene activity, viral infections, and other biological signals, capable of picking up as few as 2 to 3 target molecules in a sample.
Why RNA Needs an Extra Step
Standard PCR, the workhorse of molecular biology, only works on DNA. But many of the things scientists and clinicians want to measure exist as RNA: the messenger molecules your cells produce when genes are active, or the genetic material inside viruses like SARS-CoV-2, HIV, and hepatitis C. To analyze RNA with PCR, you first need to convert it into a DNA copy. That conversion step, called reverse transcription, is what separates qRT-PCR from plain qPCR.
This distinction matters more than it might seem. The terms RT-PCR, qPCR, and qRT-PCR are frequently used interchangeably, but they describe different things. RT-PCR refers to reverse transcription followed by standard PCR amplification, with no real-time measurement. qPCR is real-time quantitative PCR that starts with DNA, not RNA. qRT-PCR combines both: it converts RNA to DNA and then quantifies the result in real time. The MIQE guidelines, a widely adopted set of reporting standards for this technology, specifically clarify that “RT-PCR” should never be used to mean “real-time PCR,” though this confusion persists everywhere from news articles to scientific papers.
How the Process Works
qRT-PCR unfolds in two main phases. The first phase, reverse transcription, converts RNA into complementary DNA (cDNA). The second phase, quantitative PCR, amplifies that cDNA and measures how much is produced during each cycle of amplification.
Reverse Transcription
RNA extracted from a biological sample (blood, tissue, a nasal swab) is heated to 65°C to 70°C for 5 to 10 minutes to unravel its folded structures. Short DNA sequences called primers then bind to the RNA, giving the reverse transcriptase enzyme a starting point. That enzyme builds a single strand of cDNA from the RNA template, working at 37°C to 50°C for 30 to 60 minutes depending on the specific enzyme used. Finally, the reaction is stopped by heating to 70°C to 85°C, which deactivates the enzyme.
Quantitative PCR
The cDNA then enters repeated heating and cooling cycles, typically 30 to 40 of them. Each cycle has three temperature stages: heating to 95°C separates the two DNA strands, cooling to 55°C to 65°C allows primers to attach, and holding at 72°C lets a DNA-copying enzyme extend new strands. Every cycle roughly doubles the amount of target DNA. A fluorescent signal is measured at the end of each cycle to track this accumulation in real time.
How Fluorescence Becomes a Measurement
The key output of qRT-PCR is the cycle threshold, or Ct value. This is the cycle number at which the fluorescent signal rises above background noise and becomes detectable. A sample with a lot of starting RNA reaches that threshold quickly, producing a low Ct value. A sample with very little RNA takes many more cycles to generate enough signal, producing a high Ct value. The relationship is inverse: lower Ct means more target RNA was present in the original sample.
During the COVID-19 pandemic, Ct values became a familiar concept because they served as a rough proxy for viral load. A patient with high levels of SARS-CoV-2 RNA would produce a low Ct value, while someone with a fading infection might have a high one. The same principle applies to monitoring HIV patients on antiviral therapy, where qRT-PCR tracks whether the medication is keeping viral replication suppressed.
Two Ways to Detect the Signal
There are two main approaches to generating the fluorescent signal that makes real-time quantification possible, and they differ in cost, simplicity, and accuracy.
The first uses an intercalating dye that glows when it binds to double-stranded DNA. As more DNA is produced each cycle, more dye binds and the fluorescence increases. This approach is inexpensive and easy to set up, but it has a significant limitation: the dye binds to any double-stranded DNA, not just the target sequence. If the reaction accidentally produces unwanted byproducts (like primer fragments sticking together), the dye will bind to those too, potentially inflating the signal.
The second approach uses sequence-specific probes. These are short DNA fragments designed to match only the target sequence, labeled with two molecules: a reporter that fluoresces and a quencher that suppresses that fluorescence. When the probe is intact, the quencher keeps the reporter silent. During amplification, the DNA-copying enzyme chews through the probe, separating the reporter from the quencher and releasing the fluorescent signal. Because the probe only binds to the exact target sequence, this method is more specific. It costs more per reaction, but it eliminates the false-positive risk that comes with nonspecific dyes.
One-Step vs. Two-Step Protocols
Labs can run qRT-PCR as either a one-step or two-step process, and the choice involves real trade-offs.
In a one-step protocol, reverse transcription and PCR amplification happen in the same tube, one right after the other. This is faster to set up, less expensive, and reduces the risk of contamination since you’re opening fewer tubes and transferring fewer liquids. It’s the go-to format for high-throughput diagnostic testing, like processing hundreds of COVID-19 samples. The downside is that gene-specific primers must be used for the reverse transcription step, so all the cDNA produced is specific to one target. If you later want to test for a different gene, you need to go back to the original RNA sample.
In a two-step protocol, reverse transcription happens first in a separate tube, converting all the RNA in the sample into a broad library of cDNA. That cDNA can then be stored and used for multiple qPCR experiments targeting different genes. This is more flexible for research, where scientists often want to measure the activity of many genes from a single sample. The two-step approach also avoids a subtle technical problem: in one-step reactions, the efficiency of the reverse transcription can vary depending on how much total RNA is in the tube, which can skew results when building a standard curve for quantification.
What qRT-PCR Is Used For
The most visible application is infectious disease diagnosis. qRT-PCR detects the RNA of viruses that use RNA as their genetic material, including SARS-CoV-2, influenza, HIV, hepatitis C, and West Nile virus. Beyond simple yes-or-no detection, it quantifies viral load, which helps clinicians decide on treatment and monitor whether therapies are working. Organ and tissue donation programs use it to screen donors for HIV, hepatitis B and C, and other transmissible infections.
In research and oncology, qRT-PCR measures gene expression, revealing which genes are turned on or off in a given tissue and by how much. Cancer researchers use it to track how tumor cells respond to drugs. Developmental biologists use it to map how gene activity shifts as organisms grow. Because it can detect changes in gene activity with extraordinary sensitivity, it remains a standard tool even as newer technologies emerge.
Making the Numbers Reliable
Raw Ct values don’t mean much on their own because small differences in sample preparation, RNA quality, or reaction efficiency can shift results. To account for this, every qRT-PCR experiment includes internal controls: reference genes whose activity stays constant regardless of the experimental conditions. Common choices include genes involved in basic cellular functions like energy metabolism, protein production, and structural maintenance. By comparing the Ct value of the target gene to the Ct of these stable reference genes, researchers can normalize their data and make meaningful comparisons between samples.
The MIQE guidelines, published in 2009, established a standardized checklist for reporting qPCR and qRT-PCR experiments. They require full disclosure of reagents, primer sequences, and analysis methods so that other researchers can reproduce results. Before these guidelines, inconsistent reporting made it difficult to compare findings across labs, a problem that undermined confidence in published gene expression data. Journals increasingly require MIQE compliance as a condition of publication.